Registered entities
Xeris Pharmaceuticals, Inc.
Reg. No. 203352427United States
Xeris Pharmaceuticals Inc
Reg. No. 1346302United States
XERIS BIOPHARMA HOLDINGS, INC.
Reg. No. 1867096United States
XERIS CORP.
Reg. No. 850562995Belgium
Social engagement
Social engagement: 35K social following, 10 posts in the last 12 months — below the industry typical range.
Investor mix
20 investors on record; lead investors include Redmile Group, Central Texas Angel Network, Austin Technology Incubator, Merieux Equity Partners; 1 has since exited.
| Investor type | Count | Share |
|---|---|---|
| Venture capital | 4 | 20% |
| Private equity | 2 | 10% |
| Angel & family office | 2 | 10% |
| Accelerator & incubator | 1 | 5% |
| Bank & private debt | 2 | 10% |
| Other / undisclosed | 9 | 45% |
Hiring activity
Hires frequently
29 roles tracked across 6 of the last 12 months
4 Feb 2026 · Product Development (Analytical) Intern · Chicago
3 Feb 2026 · Medical Writer · Chicago
2 Feb 2026 · Clinical Project Manager · Chicago
12 Jan 2026 · Pharmaceutical Sales Representative, Endocrinology (Rare Disease) - Detroit South · Detroit
12 Jan 2026 · Pharmaceutical Sales Representative, Neurology (Rare Disease) - Gulf Coast · Montgomery
Based on job postings tracked across public sources.
Recent activity
11 Jun 2026
Event
ENDO 2026
10 Jun 2026
Recognition
regulatory
5 Jun 2026
Event
American Diabetes Association 2026 Scientific Sessions (ADASciSessions)